帕金森病患者脑脊液中生长抑素样免疫反应性及其与痴呆的关系。
Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
作者信息
Jolkkonen J, Soininen H, Halonen T, Ylinen A, Laulumaa V, Laakso M, Riekkinen P
出版信息
J Neurol Neurosurg Psychiatry. 1986 Dec;49(12):1374-7. doi: 10.1136/jnnp.49.12.1374.
Abstract
Acetylcholinesterase, somatostatin-like immunoreactivity, and homovanillic acid levels were measured in the cerebrospinal fluid of 36 patients with early stages of Parkinson's disease and in 19 control patients. In patients with Parkinson's disease the levels of somatostatin-like immunoreactivity were lower than in the controls (p less than 0.01); these values were lowest in the demented Parkinsonian patients. Concentrations of homovanillic acid were also significantly lower in Parkinsonian patients (p less than 0.05). In contrast, no changes were observed in the acetylcholinesterase activity of patients with Parkinson's disease. The reduced somatostatin-like immunoreactivity in CSF agrees with previous post-mortem studies and indicates that Parkinson's disease and Alzheimer's disease may have some neurochemical features in common.
摘要
在36例帕金森病早期患者及19例对照患者的脑脊液中检测了乙酰胆碱酯酶、生长抑素样免疫反应性和高香草酸水平。帕金森病患者的生长抑素样免疫反应性水平低于对照组（p<0.01）；这些值在帕金森病痴呆患者中最低。帕金森病患者的高香草酸浓度也显著降低（p<0.05）。相比之下，帕金森病患者的乙酰胆碱酯酶活性未观察到变化。脑脊液中生长抑素样免疫反应性降低与先前的尸检研究一致，表明帕金森病和阿尔茨海默病可能有一些共同的神经化学特征。
相似文献
1
Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.帕金森病患者脑脊液中生长抑素样免疫反应性及其与痴呆的关系。
J Neurol Neurosurg Psychiatry. 1986 Dec;49(12):1374-7. doi: 10.1136/jnnp.49.12.1374.
2
Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.帕金森病老年及痴呆患者体内的生长抑素样免疫反应性、其分子形式及单胺能代谢产物——左旋多巴的影响
J Neural Transm (Vienna). 1996;103(5):591-602. doi: 10.1007/BF01273156.
3
Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study.阿尔茨海默病和帕金森病相关痴呆中血管紧张素转换酶、乙酰胆碱酯酶及多巴胺代谢产物的脑脊液水平：一项相关性研究
Biol Psychiatry. 1986 Dec;21(14):1365-81. doi: 10.1016/0006-3223(86)90328-8.
4
Parkinson's disease and dementia: clinical and neurochemical correlations.
Neuroreport. 1992 May;3(5):413-6. doi: 10.1097/00001756-199205000-00009.
5
CSF cyclic nucleotides and somatostatin in Parkinson's disease.
Neurology. 1986 Jan;36(1):89-92. doi: 10.1212/wnl.36.1.89.
6
Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls.阿尔茨海默病、帕金森病和肌萎缩侧索硬化症患者及正常对照者脑脊液中的神经化学标志物。
J Neural Transm Park Dis Dement Sect. 1992;4(1):53-68. doi: 10.1007/BF02257622.
7
Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy.
J Am Geriatr Soc. 1990 Jan;38(1):19-24. doi: 10.1111/j.1532-5415.1990.tb01591.x.
8
Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings.帕金森病。偏侧性与痴呆及神经化学发现之间的可能关系。
Arch Neurol. 1984 Sep;41(9):935-41. doi: 10.1001/archneur.1984.04050200041016.
9
CSF somatostatin-like immunoreactivity in dementia of Parkinson's disease.帕金森病性痴呆患者脑脊液中生长抑素样免疫反应性
J Neurol Neurosurg Psychiatry. 1990 Dec;53(12):1105-6. doi: 10.1136/jnnp.53.12.1105-a.
10
Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile parkinsonian patients.
Eur Neurol. 1989;29(1):1-5. doi: 10.1159/000116366.
引用本文的文献
1
Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.帕金森病患者的脑脊液生化研究：寻找这种疾病潜在生物标志物的方法。
Front Cell Neurosci. 2014 Nov 11;8:369. doi: 10.3389/fncel.2014.00369. eCollection 2014.
2
Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach.用于帕金森病的诊断性脑脊液生物标志物：基于发病机制的方法。
Neurobiol Dis. 2010 Sep;39(3):229-41. doi: 10.1016/j.nbd.2010.04.020. Epub 2010 May 6.
3
Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.帕金森病老年及痴呆患者体内的生长抑素样免疫反应性、其分子形式及单胺能代谢产物——左旋多巴的影响
J Neural Transm (Vienna). 1996;103(5):591-602. doi: 10.1007/BF01273156.
4
A long-term follow-up study of cerebrospinal fluid acetylcholinesterase in delirium.谵妄患者脑脊液乙酰胆碱酯酶的长期随访研究
Eur Arch Psychiatry Clin Neurosci. 1994;243(6):347-51. doi: 10.1007/BF02195729.
5
Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients.弥漫性路易体病。6例患者的神经病理学和生化研究。
Acta Neuropathol. 1987;75(1):8-15. doi: 10.1007/BF00686786.
6
Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.阿尔茨海默病患者脑脊液、血浆和红细胞中的胆碱酯酶。
J Neural Transm. 1989;75(2):119-27. doi: 10.1007/BF01677425.
7
Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.弥漫性路易体病：老年斑的光镜和电镜免疫细胞化学研究
Acta Neuropathol. 1989;78(6):572-84. doi: 10.1007/BF00691284.
本文引用的文献
1
A rating scale for depression.一种抑郁症评定量表。
J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56.
2
A new and rapid colorimetric determination of acetylcholinesterase activity.一种新的快速比色法测定乙酰胆碱酯酶活性。
Biochem Pharmacol. 1961 Jul;7:88-95. doi: 10.1016/0006-2952(61)90145-9.
3
Dementia associated with Parkinson's disease: a genetic study.帕金森病伴发的痴呆：一项遗传学研究。
J Neurol Neurosurg Psychiatry. 1980 Sep;43(9):846-8. doi: 10.1136/jnnp.43.9.846.
4
Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations.帕金森病、痴呆与阿尔茨海默病：临床病理相关性
Ann Neurol. 1980 Apr;7(4):329-35. doi: 10.1002/ana.410070408.
5
A new clinical scale for the staging of dementia.一种用于痴呆分期的新临床量表。
Br J Psychiatry. 1982 Jun;140:566-72. doi: 10.1192/bjp.140.6.566.
6
Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.帕金森病患者中与痴呆相关的毒蕈碱结合及胆碱乙酰转移酶活性
Brain Res. 1982 Jan 28;232(1):129-39. doi: 10.1016/0006-8993(82)90615-1.
7
A subcortico-cortical cholinergic system is affected in Parkinson's disease.帕金森病会影响皮质下-皮质胆碱能系统。
Brain Res. 1983 Dec 12;288(1-2):213-8. doi: 10.1016/0006-8993(83)90096-3.
8
Methionine-enkephalin, substance P, and homovanillic acid in the CSF of parkinsonian patients.
Neurology. 1984 Apr;34(4):516-9. doi: 10.1212/wnl.34.4.516.
9
Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain.高效液相色谱-电化学检测法在神经化学分析中的应用：大鼠脑中儿茶酚胺、5-羟色胺及其代谢产物的测定
J Neurosci Methods. 1981 Feb;3(3):207-24. doi: 10.1016/0165-0270(81)90056-x.
10
How common is dementia in Parkinson's disease?帕金森病中痴呆症的发病率有多高？
Lancet. 1984 Dec 1;2(8414):1262-5. doi: 10.1016/s0140-6736(84)92807-1.
Zotero 插件